Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Ensure Drug Regimen Free from Unnecessary Antipsychotic Medication

Valhalla, New York Survey Completed on 11-20-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency was identified when a resident with diagnoses of cerebral ischemia, dementia without behavioral disturbance, and psychosis was prescribed Haldol 2 mg every six hours without a clearly documented indication and without consideration of psychiatric recommendations to decrease the dosage. The resident's medical records showed that Haldol was initially ordered as needed for psychosis following a hospital discharge, but the order was later changed to a scheduled dose every six hours after the resident exhibited behavioral disturbances. The facility's policy required that psychotropic medications only be prescribed when necessary to treat a specific, diagnosed condition based on a comprehensive review, but documentation did not show that this process was followed. Additionally, the pharmacist flagged the Haldol order as off-label and recommended a risk-benefit assessment, but there was no evidence this was completed. Further, a psychiatry consult recommended reducing the Haldol dosage, but there was no documentation that the physician reviewed or responded to this recommendation. The care plan did not include interventions to address the risks and side effects associated with Haldol use. Observations during the survey period found the resident confused, incoherent, and inappropriately dressed, as well as sleeping in a wheelchair. Interviews with the psychiatrist and medical director revealed a lack of communication and follow-through regarding medication changes, with the medical director unaware of the psychiatrist's recommendation to reduce the Haldol dosage.

An unhandled error has occurred. Reload 🗙